205 related articles for article (PubMed ID: 30620384)
1. The role of vascular endothelial growth factor, interleukin 8, and insulinlike growth factor in sustaining autophagic DIRAS3-induced dormant ovarian cancer xenografts.
Mao W; Peters HL; Sutton MN; Orozco AF; Pang L; Yang H; Lu Z; Bast RC
Cancer; 2019 Apr; 125(8):1267-1280. PubMed ID: 30620384
[TBL] [Abstract][Full Text] [Related]
2. ARHI (DIRAS3) induces autophagy in ovarian cancer cells by downregulating the epidermal growth factor receptor, inhibiting PI3K and Ras/MAP signaling and activating the FOXo3a-mediated induction of Rab7.
Lu Z; Yang H; Sutton MN; Yang M; Clarke CH; Liao WS; Bast RC
Cell Death Differ; 2014 Aug; 21(8):1275-89. PubMed ID: 24769729
[TBL] [Abstract][Full Text] [Related]
3. ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts.
Washington MN; Suh G; Orozco AF; Sutton MN; Yang H; Wang Y; Mao W; Millward S; Ornelas A; Atkinson N; Liao W; Bast RC; Lu Z
Cell Death Dis; 2015 Aug; 6(8):e1836. PubMed ID: 26247722
[TBL] [Abstract][Full Text] [Related]
4. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells.
Lu Z; Luo RZ; Lu Y; Zhang X; Yu Q; Khare S; Kondo S; Kondo Y; Yu Y; Mills GB; Liao WS; Bast RC
J Clin Invest; 2008 Dec; 118(12):3917-29. PubMed ID: 19033662
[TBL] [Abstract][Full Text] [Related]
5. Elimination of dormant, autophagic ovarian cancer cells and xenografts through enhanced sensitivity to anaplastic lymphoma kinase inhibition.
Blessing AM; Santiago-O'Farrill JM; Mao W; Pang L; Ning J; Pak D; Bollu LR; Rask P; Iles L; Yang H; Tran S; Elmir E; Bartholomeusz G; Langley R; Lu Z; Bast RC
Cancer; 2020 Aug; 126(15):3579-3592. PubMed ID: 32484926
[TBL] [Abstract][Full Text] [Related]
6. RAS-related GTPases DIRAS1 and DIRAS2 induce autophagic cancer cell death and are required for autophagy in murine ovarian cancer cells.
Sutton MN; Yang H; Huang GY; Fu C; Pontikos M; Wang Y; Mao W; Pang L; Yang M; Liu J; Parker-Thornburg J; Lu Z; Bast RC
Autophagy; 2018; 14(4):637-653. PubMed ID: 29368982
[TBL] [Abstract][Full Text] [Related]
7. Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel.
Zou CF; Jia L; Jin H; Yao M; Zhao N; Huan J; Lu Z; Bast RC; Feng Y; Yu Y
BMC Cancer; 2011 Jan; 11():22. PubMed ID: 21244707
[TBL] [Abstract][Full Text] [Related]
8. DIRAS3 regulates the autophagosome initiation complex in dormant ovarian cancer cells.
Lu Z; Baquero MT; Yang H; Yang M; Reger AS; Kim C; Levine DA; Clarke CH; Liao WS; Bast RC
Autophagy; 2014 Jun; 10(6):1071-92. PubMed ID: 24879154
[TBL] [Abstract][Full Text] [Related]
9. Expression and epigenetic regulation of angiogenesis-related factors during dormancy and recurrent growth of ovarian carcinoma.
Lyu T; Jia N; Wang J; Yan X; Yu Y; Lu Z; Bast RC; Hua K; Feng W
Epigenetics; 2013 Dec; 8(12):1330-46. PubMed ID: 24135786
[TBL] [Abstract][Full Text] [Related]
10. The tumour suppressor DiRas3 interacts with C-RAF and downregulates MEK activity to restrict cell migration.
Klingauf M; Beck M; Berge U; Turgay Y; Heinzer S; Horvath P; Kroschewski R
Biol Cell; 2013 Feb; 105(2):91-107. PubMed ID: 23157514
[TBL] [Abstract][Full Text] [Related]
11. Distinct subgroup of the Ras family member 3 (DIRAS3) expression impairs metastasis and induces autophagy of gastric cancer cells in mice.
Qiu J; Li X; He Y; Sun D; Li W; Xin Y
J Cancer Res Clin Oncol; 2018 Oct; 144(10):1869-1886. PubMed ID: 30043279
[TBL] [Abstract][Full Text] [Related]
12. Induction of autophagy by ARHI (DIRAS3) alters fundamental metabolic pathways in ovarian cancer models.
Ornelas A; McCullough CR; Lu Z; Zacharias NM; Kelderhouse LE; Gray J; Yang H; Engel BJ; Wang Y; Mao W; Sutton MN; Bhattacharya PK; Bast RC; Millward SW
BMC Cancer; 2016 Oct; 16(1):824. PubMed ID: 27784287
[TBL] [Abstract][Full Text] [Related]
13. Re-expression of DIRAS3 and p53 induces apoptosis and impaired autophagy in head and neck squamous cell carcinoma.
Liu Z; Hurst DR; Qu X; Lu LG; Wu CZ; Li YY; Li Y
Mil Med Res; 2020 Oct; 7(1):48. PubMed ID: 33038921
[TBL] [Abstract][Full Text] [Related]
14. Targeting the insulin growth factor and the vascular endothelial growth factor pathways in ovarian cancer.
Shao M; Hollar S; Chambliss D; Schmitt J; Emerson R; Chelladurai B; Perkins S; Ivan M; Matei D
Mol Cancer Ther; 2012 Jul; 11(7):1576-86. PubMed ID: 22700681
[TBL] [Abstract][Full Text] [Related]
15. DIRAS3: An Imprinted Tumor Suppressor Gene that Regulates RAS and PI3K-driven Cancer Growth, Motility, Autophagy, and Tumor Dormancy.
Bildik G; Liang X; Sutton MN; Bast RC; Lu Z
Mol Cancer Ther; 2022 Jan; 21(1):25-37. PubMed ID: 34667114
[TBL] [Abstract][Full Text] [Related]
16. Weight Loss Upregulates the Small GTPase DIRAS3 in Human White Adipose Progenitor Cells, Which Negatively Regulates Adipogenesis and Activates Autophagy via Akt-mTOR Inhibition.
Ejaz A; Mitterberger MC; Lu Z; Mattesich M; Zwierzina ME; Hörl S; Kaiser A; Viertler HP; Rostek U; Meryk A; Khalid S; Pierer G; Bast RC; Zwerschke W
EBioMedicine; 2016 Apr; 6():149-161. PubMed ID: 27211557
[TBL] [Abstract][Full Text] [Related]
17. DIRAS3-Derived Peptide Inhibits Autophagy in Ovarian Cancer Cells by Binding to Beclin1.
Sutton MN; Huang GY; Liang X; Sharma R; Reger AS; Mao W; Pang L; Rask PJ; Lee K; Gray JP; Hurwitz AM; Palzkill T; Millward SW; Kim C; Lu Z; Bast RC
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 31003488
[TBL] [Abstract][Full Text] [Related]
18. DIRAS3 induces autophagy and enhances sensitivity to anti-autophagic therapy in KRAS-driven pancreatic and ovarian carcinomas.
Bildik G; Gray JP; Mao W; Yang H; Ozyurt R; Orellana VR; De Wever O; Carey MS; Bast RC; Lu Z
Autophagy; 2024 Mar; 20(3):675-691. PubMed ID: 38169324
[TBL] [Abstract][Full Text] [Related]
19. Combination of erlotinib and a PARP inhibitor inhibits growth of A2780 tumor xenografts due to increased autophagy.
Sui H; Shi C; Yan Z; Li H
Drug Des Devel Ther; 2015; 9():3183-90. PubMed ID: 26124641
[TBL] [Abstract][Full Text] [Related]
20. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
Zhang XY; Zhang M; Cong Q; Zhang MX; Zhang MY; Lu YY; Xu CJ
Int J Biochem Cell Biol; 2018 Feb; 95():9-16. PubMed ID: 29247711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
